高分辨率图像下载与演示文稿下载。Complement component 5 (C5)是补体级联反应的关键蛋白，其抑制剂开发对重症肌无力（gMG）等自身免疫疾病至关重要。本文系统阐述zilucoplan从mRNA展示筛选到临床批准的全程研发，重点包括：1）通过mRNA展示技术获得初始候选肽（化合 ...
NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB) today announced positive topline results from its Phase 1 single ascending dose (SAD) study in healthy participants of RLYB116, ...
NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB) today announced preliminary Phase 1 multiple ascending dose (MAD) data for RLYB116, an innovative, long-acting, low volume ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果